Stem Announces Notification of Noncompliance with NYSE Continued Listing Standards
Key Highlights
- ➤Stem (STEM) notified NYSE it failed the $50 million market-capitalization and equity standard.
- ➤NYSE confirmed noncompliance on October 20, 2026, triggering a formal cure process.
- ➤Stem plans to submit a compliance business plan within 45 days.
- ➤NYSE could allow 18 months to regain compliance, with quarterly monitoring.
- ➤Stem’s stock remains listed during the cure period, subject to NYSE conditions.
Stem Announces Notification of Noncompliance with NYSE Continued Listing Standards
Stem, Inc. (NYSE: STEM), a global leader in AI-enabled clean energy software and services, today announced that on October 19, 2026, it had notified the New York Stock Exchange (the “NYSE”) that the Company is not in compliance with Section 802.01B of the NYSE Listed Company Manual (the “Manual”), which requires a listed company’s average global market capitalization over a consecutive 30 trading-day period to be not less than $50 million and, at the same time, its stockholders’ equity to be not less than $50 million. On October 20, 2026, the Company received a non-compliance letter from the NYSE confirming that the Company is not in compliance with the requirement of Section 802.01B of the Manual (the “NYSE Letter”).
Get started
Create a free account to read the full story.